SMMT
Summit Therapeutics Inc.
$21.89-0.23 (-1.04%)
Price
MA20
▲Insider buy
▼Insider sell
Loading chart...
🤖 AI InsightHaiku 4.5
Summit Therapeutics Inc. (SMMT) is a publicly traded company with no SEC Form 4 insider transactions reported in the past 90 days. Form 4 filings disclose insider stock activity within two business days. The absence of recent filings can reflect either a stable insider holding pattern or simply no recent transactions to report. Historical filings, if any, remain searchable below.
Latest Insider Transactions
Showing 10 of 40 transactions (past 365 days)
| 1WStock price change 1 week after insider bought. Small number below shows return vs S&P 500. | 1MStock price change 1 month after insider bought. | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2026-01-12 | 2026-01-08 | Anand Bhaskar | CAO | Award | 30,000 | $0.00 | $0 | N/A | N/A |
| 2026-01-06 | 2026-01-02 | Cesano Alessandra | Director | Award | 3,219 | $8.76 | $28,198 | N/A | N/A |
| 2026-01-06 | 2026-01-02 | Booth Robert F. | Director | Award | 35,000 | $0.00 | $0 | N/A | N/A |
| 2026-01-06 | 2026-01-02 | Cesano Alessandra | Director | Award | 35,000 | $0.00 | $0 | N/A | N/A |
| 2026-01-06 | 2026-01-02 | Huber Jeff | Director | Award | 9,885 | $8.76 | $86,593 | N/A | N/A |
| 2026-01-06 | 2026-01-02 | Clark Kenneth A | Director | Award | 35,000 | $0.00 | $0 | N/A | N/A |
| 2026-01-06 | 2026-01-02 | Booth Robert F. | Director | Award | 7,180 | $8.76 | $62,897 | N/A | N/A |
| 2026-01-06 | 2026-01-02 | Duggan Robert W | CEO | Award | 11,232 | $8.76 | $98,392 | N/A | N/A |
| 2026-01-06 | 2026-01-02 | Clark Kenneth A | Director | Award | 17,796 | $8.76 | $155,893 | N/A | N/A |
| 2026-01-06 | 2026-01-02 | Xia Yu | Director | Award | 35,000 | $0.00 | $0 | N/A | N/A |
Want to see more transactions?
Sign up for free to unlock more insider transactions and create watchlists.